Medicare Transaction Fraud Prevention Act
- Bill Number
- S. 2066
- Origin Chamber
- Senate
- Congress
- 119th Congress, Session 1
- Policy Area
- Health
- Status
- Introduced
- Latest Action
- 2025-06-12: Read twice and referred to the Committee on Finance.
- Last Updated
- 2025-12-05T22:05:51Z
AI-Generated Summary
Purpose of the Legislation
The Medicare Transaction Fraud Prevention Act (S. 2066) aims to reduce fraud and abuse in Medicare payments by establishing a two-year pilot program. This program tests a predictive risk-scoring algorithm—an AI tool that analyzes data to identify potentially suspicious claims—for overseeing payments related to durable medical equipment (DME, such as wheelchairs or oxygen tanks) and clinical diagnostic laboratory tests (like blood work).
Key Provisions
- Pilot Program Setup: The U.S. Secretary of Health and Human Services (HHS) must launch the program by January 1, 2026, for a duration of two years. It focuses on claims (called "relevant transactions") for DME or lab tests provided to "applicable beneficiaries"—Medicare enrollees who voluntarily opt in and agree to receive electronic Medicare Summary Notices (monthly statements of benefits).
- Voluntary Participation: Beneficiaries can join or leave the program at any time, ensuring it's not mandatory.
- Risk-Scoring Algorithm: The algorithm assigns scores from 1 (lowest risk) to 99 (highest risk) to claims, using factors like:
- No prior relationship between the beneficiary and the provider or supplier.
- Unusual billing patterns, such as high claim volumes in one area.
- Changes in electronic fund transfers or ownership of providers/suppliers.
- Implementation Requirements:
- Collaborate with industry groups, including DME suppliers, during development.
- Test and review the algorithm thoroughly, following Executive Order 14179 (which promotes U.S. leadership in AI by removing barriers).
- Notify participants (beneficiaries and providers) about how their data is used, including data collection, processing, and potential effects.
- Coordinate with the HHS Office of the Inspector General (OIG) for oversight, with options to waive notices in certain cases.
- Response to High-Risk Claims:
- For claims scoring above a set risk threshold, conduct a human review to decide if payment should be paused temporarily.
- Allow beneficiaries to respond via email or phone to correct errors or confirm the claim.
- If paused, send automatic electronic alerts via Medicare Summary Notices every two weeks for three months, including tips on reporting suspected fraud to law enforcement.
- Additional Authority: HHS can issue new Medicare cards or terminate old ones to prevent fraud.
- Human Oversight: Any pauses in payments must involve human review, not just the algorithm's output.
Significant Changes to Existing Law
This bill amends Section 1128K of the Social Security Act (which currently addresses Medicare fraud and abuse reporting). It adds a new subsection (d) specifically for the pilot program, introducing AI-based predictive scoring as a new tool for transaction oversight. Previously, oversight relied more on manual reviews and reporting; this adds automated risk assessment while keeping human judgment central. The change also updates the section's heading to reflect the pilot program's focus on DME and lab tests.
Potential Impacts
- Government Agencies: HHS will need resources for developing, testing, and running the algorithm, potentially improving fraud detection efficiency and saving Medicare funds (estimated billions lost annually to fraud). It may increase coordination with the OIG and require new data privacy protocols.
- Citizens (Medicare Beneficiaries): Opted-in users may face more frequent notices and temporary payment holds, but they gain tools to spot and report fraud, protecting their benefits. Non-opted-in beneficiaries are unaffected, minimizing broad disruption.
- Providers and Suppliers: Could lead to faster fraud investigations, reducing improper payments but possibly delaying legitimate claims during reviews. Industry collaboration may foster better compliance practices.
- International Relations: No direct impact, as this is a domestic Medicare program.
Main Stakeholders Affected
- Medicare Beneficiaries: Primarily those opting in, who provide data and receive enhanced fraud alerts.
- Healthcare Providers and Suppliers: Including DME companies (e.g., medical equipment vendors) and labs, subject to risk scoring and potential payment reviews.
- HHS and OIG: Responsible for program administration, algorithm testing, and enforcement.
- Industry Representatives: DME suppliers and lab operators, involved in program development to ensure practical implementation.
Notable Legal, Constitutional, or Political Implications
- Privacy and Data Use: The program involves collecting and processing beneficiary data for AI analysis, raising potential concerns under laws like HIPAA (Health Insurance Portability and Accountability Act, which protects health information privacy). Notifications and opt-in requirements help address consent, but thorough testing is mandated to avoid biases or errors in AI scoring.
- Constitutional Aspects: Voluntary participation respects individual rights (e.g., due process under the Fifth Amendment) by allowing opt-outs and human reviews, preventing arbitrary government actions. No forced data sharing avoids Fourth Amendment search issues.
- Political Implications: References to Executive Order 14179 signal a push for innovative AI use in government while emphasizing U.S. competitiveness. As a pilot, it allows evaluation before wider adoption, potentially influencing future anti-fraud policies amid debates on AI ethics, government spending, and healthcare costs. Bipartisan sponsorship (from Senators Sheehy, Hassan, Schmitt, and Cassidy) suggests broad support for fraud prevention without major controversy.
This summary was generated by AI and may contain inaccuracies. Refer to the official source document for the authoritative text.
Sponsor
Cosponsors (3)
Sen. Hassan, Margaret Wood [D-NH], Sen. Schmitt, Eric [R-MO], Sen. Cassidy, Bill [R-LA]
Recent Actions
- 2025-06-12: Read twice and referred to the Committee on Finance.
- 2025-06-12: Introduced in Senate
Bill Versions
- Medicare Transaction Fraud Prevention Act — issued 2025-06-12 — PDF (8 pages)